Cardiovascular adverse events associated with immune checkpoint inhibitors: a meta-analysis
ObjectiveTo evaluate the cardiovascular safety of anticancer drug immune checkpoint inhibitors (ICIs) used in patients with malignant tumors.MethodsFour clinical research databases that have been completed since their establishment were searched, and t…